Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MediWound (MDWD) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for MediWound (MDWD) over the last 13 years, with Q2 2025 value amounting to $1.5 million.

  • MediWound's Other Operating Expenses rose 1944.44% to $1.5 million in Q2 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 3565.22%. This contributed to the annual value of $18000.0 for FY2024, which is 10853.08% up from last year.
  • Per MediWound's latest filing, its Other Operating Expenses stood at $1.5 million for Q2 2025, which was up 1944.44% from $18000.0 recorded in Q4 2024.
  • In the past 5 years, MediWound's Other Operating Expenses registered a high of $1.5 million during Q2 2025, and its lowest value of -$224000.0 during Q3 2023.
  • For the 5-year period, MediWound's Other Operating Expenses averaged around $754583.3, with its median value being $863000.0 (2021).
  • Per our database at Business Quant, MediWound's Other Operating Expenses crashed by 9653.33% in 2023 and then skyrocketed by 57455.36% in 2024.
  • Quarter analysis of 5 years shows MediWound's Other Operating Expenses stood at $872000.0 in 2021, then tumbled by 57.0% to $375000.0 in 2022, then tumbled by 96.53% to $13000.0 in 2023, then soared by 38.46% to $18000.0 in 2024, then surged by 8022.22% to $1.5 million in 2025.
  • Its Other Operating Expenses was $1.5 million in Q2 2025, compared to $18000.0 in Q4 2024 and $1.1 million in Q3 2024.